Pituitary Gland
New consensus statement addresses advances in diagnosing, managing prolactinomas
The way endocrinologists manage prolactinomas is changing.
Genetic aspects of pituitary tumors: A conversation with Márta Korbonits, MD, PhD, DSc
Márta Korbonits, MD, PhD, DSc, FRCP, uncovered a passion for endocrinology from a series of inspirational lectures during her medical training.
VIDEO: Pituitary research presented at ENDO 2023
CHICAGO —In this video exclusive, John Carmichael, MD, discusses some of the pituitary research presented at ENDO 2023, including treatments for Cushing’s syndrome and adipose effects following acromegaly cure.
VIDEO: Pituitary and adrenal research highlights from ECE 23
In this video exclusive, Maria Fleseriu, MD, FACE, reviews the pituitary and adrenal research highlights presented at ECE 2023, the annual meeting of the European Society of Endocrinology, which took place in Istanbul, Turkey, in May.
FDA approves oral treatment for Cushing’s disease
The FDA has approved the nonsteroidal corticosteroid biosynthesis inhibitor osilodrostat for adults with Cushing’s disease who cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease, according to an agency press release.
National readmission rate remains at 10% after pituitary surgery
The national 30-day unplanned readmission rate following transsphenoidal surgery for pituitary lesion held at 10.4% between 2010 and 2015, despite a national focus on reducing readmission rates, according to findings from a database analysis published in Pituitary.
Poor quality of life persists after pituitary tumor surgery
Individuals with adult-onset craniopharyngioma reported postoperative quality of life measures that were comparable with those of other primary and secondary brain tumors, despite the benign biology of the condition, according to an analysis of German registry data published in The Journal of Clinical Endocrinology & Metabolism.